Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema

NCT02329132 · clinicaltrials.gov ↗

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Ranibizumab

Sponsor

Kagawa University

Collaborators

[object Object]